The fight against infections is as old as civilization. Silver, for instance, had already been recognized in ancient Greece and Rome for its infection-fighting properties and it has a long and intriguing history as an antibiotic in human health care. Modern day pharmaceutical companies developed powerful antibiotics - which also happen to be much more profitable than just plain old silver - an apparent high-tech solution to get nasty microbes such as bacteria under control. In the 1950s, penicillin was so successful that the U.S. surgeon general at the time, William H. Stewart, declared it was "time to close the book on infectious diseases, declare the war against pestilence won." Boy, was he wrong! These days, the U.S. Centers for Disease Control and Prevention (CDC) estimates that the infections acquired in hospitals alone (of all places! it's 2007 and we can't even make our hospitals safe - how scary is that?) affect approximately 2 million persons annually. In the U.S., between 44,000 and 98,000 people die every year from infections they picked up in hospitals. As our antibiotics become more and more ineffective researchers have begun to re-evaluate old antimicrobial substances such as silver. Antimicrobial nano-silver applications have become a very popular early commercial nanotechnology product. Researchers have now made a first step to add carbon nanotubes to our microbe-killing arsenal.
There you are - a romantic dinner for two, soft jazz music in the background, exquisite French cuisine served on finest porcelain. You are sniffing that 1986 Bordeaux you kept for this special occasion. The expensive floral bouquet that is the centerpiece of the table is warmly lit by several candles. "Wait!" you think, "wouldn't the soot from these candles make a great source of fluorescent carbon nanoparticles?" Or so works the mind of a nanoscientist. This is why they make great discoveries in nanotechnology while you and I just waste a few hours on dinner. Researchers actually have just demonstrated that fluorescent nanoparticles can be prepared from a common carbon source - candle soot. The whole process is so simple it could be carried out in a freshman chemical laboratory. So chances are the dinner actually was a midnight snack over pizza and diet coke, the music was Talib Kweli, and the mood was decidedly unromantic.
In the good old days, say 5,000 years ago, a bearing was simply the placement of tree trunks under the huge stone blocks that your worker army used to construct a pyramid. Since then, bearings have become a bit more sophisticated and are an essential part of much of today's machinery. Consequently, many kinds of bearings have been developed to suit particular purposes - sliding, rolling, fluid, or magnetic bearings, to name a few major categories. Bearings are now widely used for instance to reduce friction between shafts and axles or absorb the weight placed on moving parts and they are found in applications ranging from automobiles, trains and airplanes, computers, construction equipment, machine tools, to ceiling fans and roller skates. The same way that bearings have become an integral part of our modern world, they will also play an important role in the extremely miniaturized micro- and nanodevices of the future. Engineers will just have to come up with ingenuous ways to construct bearings at the nanoscale. Carbon nanotubes (CNTs) offer one possibility. Researchers have demonstrated that the relative displacements between the atomically smooth, nested shells in multiwalled carbon nanotubes (MWCNTs) can be used as a robust nanoscale motion-enabling mechanism. Even better, a group in Switzerland has demonstrated batch fabrication of such CNT bearings is possible.
A revolutionary new environmental biotechnology - the Microbial Fuel Cell - turns the treatment of organic wastes into a source of electricity. Fuel cell technology, despite its recent popularity as a possible solution for a fossil-fuel free future, is actually quite old. The principle of the fuel cell was discovered by German scientist Christian Friedrich Schoenbein in 1838 and published in 1839. Based on this work, the first fuel cell was developed by Welsh scientist Sir William Robert Grove in 1843. The operating principle of a fuel cell is fairly straightforward. It is an electrochemical energy conversion device that converts the chemical energy from fuel (on the anode side) and oxidant (on the cathode side) directly into electricity. Today, there are many competing types of fuel cells, depending on what kind of fuel and oxidant they use. Many combinations of fuel and oxidant are possible. For instance, hydrogen cell uses hydrogen as fuel and oxygen as oxidant. Other fuels include hydrocarbons and alcohols. An interesting - but not commercially viable yet - variant of the fuel cell is the microbial fuel cell (MFC) where bacteria oxidize compounds such as glucose, acetate or wastewater. Researchers in Spain have fabricated multi-walled carbon nanotube (MWCNT) scaffolds with a micro-channel structure in which bacteria can grow. This scaffold structure could be used as electrodes in microbial fuel cells.
Curing cancer is on of the many promises of nanotechnology. Although scientists have been making amazing progress in this area, there are still significant challenges that need to be overcome before highly selective, targeted anti-cancer therapy becomes available for everyday clinical use. A nanotechnology-based system to eradicate cancer needs four elements: 1) Molecular imaging at the cellular level so that even the slightest overexpressions can be monitored; 2) effective molecular targeting after identifying specific surface or nucleic acid markers; 3) a technique to kill the cells, that are identified as cancerous based on molecular imaging, simultaneously by photodynamic therapy or drug delivery and 4) a post molecular imaging technique to monitor the therapeutic efficacy. One of the problems today is that these four techniques are used separately or ineffectively, resulting in an overall poor therapeutic outcome. In what could amount to a quantum leap in cancer nanotechnology, researchers have now integrated these techniques simultaneously in vitro and shown that this results in higher therapeutic efficacies for destroying cancer cells. Their demonstration of multi-component molecular targeting of surface receptors and subsequent photo-thermal destruction of cancer cells using single-walled carbon nanotubes (SWCNTs) could lead to a new class of molecular delivery and cancer therapeutic systems.
If you have seen the movie The Matrix then you are familiar with 'jacking in' - a brain-machine neural interface that connects a human brain to a computer network. For the time being, this is still a sci-fi scenario, but don't think that researchers are not heavily working on it. What is already reality today is something called neuroprosthetics, an area of neuroscience that uses artificial microdevices to replace the function of impaired nervous systems or sensory organs. Different biomedical devices implanted in the central nervous system, so-called neural interfaces, already have been developed to control motor disorders or to translate willful brain processes into specific actions by the control of external devices. These implants could help increase the independence of people with disabilities by allowing them to control various devices with their thoughts (not surprisingly, the other candidate for early adoption of this technology is the military). The potential of nanotechnology application in neuroscience is widely accepted. Especially single-walled carbon nanotubes (SWCNT) have received great attention because of their unique physical and chemical features, which allow the development of devices with outstanding electrical properties. In a crucial step towards a new generation of future neuroprosthetic devices, a group of European scientists developed a SWCNT/neuron hybrid system and demonstrated that carbon nanotubes can directly stimulate brain circuit activity.
The ideal drug carrier may be something out of science fiction. In principle, it is injected into the body and transports itself to the correct target, such as a tumor, and delivers the required dose at this target. This idealized concept was first proposed by Paul Ehrlich at the beginning of the 20th century and was nicknamed the "magic bullet" concept. With the advent of nanotechnology and nanomedicine this dream is rapidly becoming a reality. Nanotechnology has already been applied to drug delivery and cosmetics through the use of liposomal technology, and now nanoparticles and nanotubes present an exciting and more promising alternative.
Ethanol is all the rage these days. Although we have been drinking ethanol, an alcohol, for thousands of years (fermented beverages such as beer and wine may contain up to 15-25% ethanol by volume), the recent interest has been sparked by its use as a renewable fuel alternative to gasoline. Indeed, the largest single use of ethanol is as a motor fuel and fuel additive. Ethanol is produced by fermentation when certain species of yeast metabolize sugar. The process works with all biological feedstocks that contain appreciable amounts of sugar or materials that can be converted into sugar such as starch or cellulose. The primary feedstock for ethanol production in the U.S. is corn. In Brazil, the world's leading ethanol producer, it's mostly derived from sugar cane. While there is a heated controversy over the economic and ecological benefits of using biomass for producing ethanol fuel, it seems that nanotechnology's jack-of-all-trades, the carbon nanotube (CNT), might provide a solution here as well. CNTs are increasingly recognized as promising materials for catalysis, either as catalysts themselves, as catalyst additives or as catalyst supports. Researchers in China now have used CNTs loaded with rhodium (Rh) nanoparticles as reactors to convert a gas mixture of carbon monoxide and hydrogen into ethanol. This appears to be the first example where the activity and selectivity of a metal-catalyzed gas-phase reaction benefits significantly from proceeding inside a nanosized CNT reaction vessel.